2.60
                                            전일 마감가:
              $2.95
            열려 있는:
              $2.95
            하루 거래량:
                488.98K
            Relative Volume:
              2.72
            시가총액:
                $38.11M
            수익:
              $6.66M
            순이익/손실:
              $-25.52M
            주가수익비율:
              -2.1488
            EPS:
                -1.21
            순현금흐름:
                $-28.98M
            1주 성능:
              -31.58%
            1개월 성능:
              -31.58%
            6개월 성능:
                -49.42%
            1년 성능:
              -65.95%
            Veru Inc Stock (VERU) Company Profile
명칭
                  
                      Veru Inc
                    
                전화
                  
                      (312) 595-9123
                    
                주소
                  
                      2916 N. MIAMI AVENUE, MIAMI, FL
                    
                VERU을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                VERU
                            
                             
                        Veru Inc 
                           | 
                    2.60 | 47.35M | 6.66M | -25.52M | -28.98M | -1.21 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Veru Inc Stock (VERU) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 | 
|---|---|---|---|
| 2024-05-14 | 개시 | B. Riley Securities | Buy | 
| 2024-03-28 | 개시 | Raymond James | Outperform | 
| 2023-06-07 | 업그레이드 | Jefferies | Underperform → Hold | 
| 2021-04-13 | 개시 | Jefferies | Buy | 
| 2021-02-09 | 재확인 | H.C. Wainwright | Buy | 
| 2020-01-21 | 재확인 | H.C. Wainwright | Buy | 
| 2019-03-20 | 개시 | Oppenheimer | Outperform | 
| 2018-07-03 | 개시 | Maxim Group | Buy | 
                    모두보기
                    
                  
                Veru Inc 주식(VERU)의 최신 뉴스
Will Veru Inc. (FMW) stock see valuation expansion2025 Fundamental Recap & AI Driven Stock Price Forecasts - newser.com
Custom watchlist performance reports with Veru Inc.Trade Performance Summary & Long-Term Capital Growth Strategies - newser.com
Automated trading signals detected on Veru Inc.Fed Meeting & Smart Money Movement Tracker - newser.com
How strong is Veru Inc. stock revenue growthMarket Risk Summary & Daily Profit Focused Stock Screening - newser.com
What to expect from Veru Inc. in the next 30 days2025 Volume Leaders & Growth Focused Entry Reports - newser.com
Using AI based signals to follow Veru Inc.July 2025 Recap & Free Fast Gain Swing Trade Alerts - newser.com
Using economic indicators to assess Veru Inc. potentialShort Setup & Real-Time Volume Triggers - newser.com
Can Veru Inc. stock sustain institutional interestEarnings Overview Summary & Risk Managed Trade Strategies - newser.com
Can Veru Inc. (FMW) stock double in coming yearsJuly 2025 Volume & Capital Efficient Trading Techniques - newser.com
Why Veru Inc. stock is favored by pension fundsJuly 2025 Fed Impact & Real-Time Chart Pattern Alerts - newser.com
Why retail investors favor Veru Inc. stockPrice Action & Reliable Entry Point Trade Alerts - newser.com
Is Veru Inc. (FMW) stock expanding market penetration2025 Risk Factors & Daily Profit Maximizing Tips - newser.com
Why Veru Inc. (FMW) stock stays undervaluedQuarterly Portfolio Report & Target Return Focused Picks - newser.com
Why pension funds invest in Veru Inc. (FMW) stockJuly 2025 Analyst Calls & Safe Entry Point Alerts - newser.com
Can trapped investors hope for a rebound in Veru Inc.Weekly Trade Review & AI Forecast Swing Trade Picks - newser.com
Will Veru Inc. (FMW) stock split increase liquidityPortfolio Risk Report & Entry Point Confirmation Alerts - newser.com
Can Veru Inc. stock deliver surprise earnings beatJuly 2025 Snapshot & Advanced Swing Trade Entry Plans - newser.com
Can Veru Inc. stock resist sector downturnsMarket Volume Summary & Smart Investment Allocation Insights - newser.com
Will Veru Inc. (FMW) stock issue positive guidanceJuly 2025 Catalysts & Consistent Income Trade Recommendations - newser.com
What analysts say about Veru Inc stockValue Traps to Avoid & Free Real-Time Trading Alerts Every Day - earlytimes.in
Veru Inc. to Present Key Findings on Enobosarm at ObesityWeek 2025 - Quiver Quantitative
Veru (NASDAQ: VERU) to present enobosarm data with GLP-1RA at ObesityWeek 2025 - Stock Titan
Will Veru Inc. (FMW) stock keep raising dividendsMarket Performance Recap & Weekly Return Optimization Alerts - newser.com
How to build a custom watchlist for Veru Inc.July 2025 Rallies & Low Drawdown Investment Strategies - newser.com
Veru prices $25.2 million public offering to fund clinical studies By Investing.com - Investing.com Canada
Veru Announces Public Offering to Raise $23.4 Million - TipRanks
Veru prices 1.4M shares at $3.00 in underwritten public offering - TipRanks
Veru announces pricing of $25M public offering - TipRanks
Veru stock tumbles after pricing public offering at $3 per share - Investing.com Nigeria
Veru stock tumbles after pricing public offering at $3 per share By Investing.com - Investing.com South Africa
Veru (VERU) Unveils Public Offering to Fuel Enobosarm Developmen - GuruFocus
Veru Announces Pricing of $25 Million Public Offering - The Manila Times
Veru (NASDAQ: VERU) prices offering at $3.00; expected gross proceeds of $25.2M - Stock Titan
Does Veru Inc. qualify in momentum factor screeningWeekly Profit Recap & Verified Momentum Watchlists - newser.com
Veru Inc (VERU) 재무 분석
매출
순이익
현금흐름
주당 순 이익
                자본화:
                 
                  | 
                볼륨(24시간):